Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia

详细信息    查看全文

• 作者：Mina Kalantari ; Kathryn Osann ; Itzel E. Calleja-Macias ; Seong Kim ; Bing Yan ; Sara Jordan ; Dana M. Chase ; Krishnansu S. Tewari ; Hans-Ulrich Bernard
• 关键词：Papillomaviruses ; DAPK gene ; Epigenetics ; DNA methylation ; Biomarker ; Cancer progression
• 刊名：Virology
• 出版年：5 January, 2014
• 年：2014
• 卷：448
• 期：Complete
• 页码：314-321
• 全文大小：700 K

文摘

During progression of cervical cancer, human papillomavirus genomes and cellular tumor suppressor genes can become methylated. Toward a better understanding of these biomarkers, we studied 104 samples with HPV16, 18, 31, and 45 representing five pathological categories from asymptomatic infection to cancer. We grouped all samples by HPV type and pathology and measured the overall methylation of informative amplicons of HPV late genes and the cellular DAPK gene. Methylation of all four HPV types as well as of the DAPK gene is lowest in asymptomatic infection and increases successively in all four pathological categories during progression to cancer. 27 out of 28 cancer samples showed methylation both in the L2/L1 genes as well as in DAPK, but a much lower fraction in all other pathological categories. We discuss the problem to develop diagnostic tests based on complex methylation patterns that make it difficult to classify amplicons as 鈥渕ethylated鈥?or 鈥渦nmethylated鈥?